Bausch & Lomb Corporation (BLCO)-A Bull Case Theory [Yahoo! Finance]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Currently, BLCO stock is trading at $19.68, which is near its 52-week high of $21.69. So, BLCO stock has gained over 24% since the publication of this thesis. BLCO stock's forward PE ratio (non-GAAP) is at 32.26, and the stock is trading at 1.48 times, trailing twelve-month (TTM) sales. The thesis on Bausch & Lomb Corp. (BLCO) contends that the company is positioned for a robust upside ahead. Operating in three key segments; vision care (contact lenses and consumer eye health products), surgical equipment and consumables, and medications for eye conditions, BLCO leads worldwide in eye care. Bausch Health (BHC), the former parent company of BLCO, still owns an 88% market share. Hence, margin constraints resulting from large overhead expenses have impeded the stock performance despite its relatively strong market position. The thesis underscores that BLCO is in a phase of operational and financial transition and that its problems are transient. With their sales cycles maturing, ther
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis [Yahoo! Finance]Yahoo! Finance
- PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS [Yahoo! Finance]Yahoo! Finance
- Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of CirrhosisAccesswire
- PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSSAccesswire
- Photodynamic Therapy Market to Grow by USD 2.35 Billion (2024-2028), Driven by Rising Cancer Prevalence, AI-Powered Report Highlights Market Trends - Technavio [Yahoo! Finance]Yahoo! Finance
BHC
Earnings
- 10/30/24 - Miss
BHC
Sec Filings
- 11/1/24 - Form 8-K
- 10/31/24 - Form 10-Q
- 10/30/24 - Form 8-K
- BHC's page on the SEC website